Medicine warm winter do not forget to transition.doc

 PAGE \* MERGEFORMAT 10 Medicine warm winter do not forget to transition End of the year has passed, cold wave bursts. Many industries, the financial crisis into the cold winter, but for the pharmaceutical industry, this winter is not so cold, medicine ‘rigid requirements’, excellent growth, the Government undertakes a large number of inputs, market expansion is expected, the stock market under the action of downward rigidity in other comprehensive , making the whole pharmaceutical industry is a warm winter. At the same time, is not every business and every practitioner can feel ‘warm’ views. Looking back on 2008, the pharmaceutical industry really flies unusual: Exception actively participate in society as a whole great debate on health reform; countries in order to solve the people ‘medical care is difficult’, ‘doctor of your’ problem, they racked their brains trying to find system solutions. Number of policies, measures, practices are indeed ‘pointing its sword towards seven inches’: essential medicines system (including the ‘directory’, point production and distribution, the use of regulations), Guangdong pilot zero-slip and ‘three control’, Supreme Court, the maximum People’s Procuratorate promulgated last November 20 ‘on the handling of criminal cases of commercial bribery law applicable to a number of views on the issue’ (hereinafter ‘views’), etc., will directly affect many businesses and industries on the fate, mentality and behavior. If we say that ‘fixed’ a direct bearing on the production of medicines as part of small and medium enterprises and S amp;amp; P’s Guantingbingzhuan commercial units, then in Guangdong ‘3-control’ began to allow the pharmaceutical major contractor profit plunged becomes unprofitable, and further so as to prevent ‘down votes’ for the livelihood of small companies can sell himself; houses put the ‘comments’ will allow pharmaceutical representatives and doctors subtle psychological changes occur. Industry face the problem